For US residents only.

Sign Up for Support


PROMACTA Patient Support Program Registration


Taking medicine is an important part of managing your condition. In addition, getting the right support and resources may help you stay on track and keep a positive outlook. Created with your needs in mind, the PROMACTA® (eltrombopag) Patient Support Program provides support for patients who have been diagnosed with chronic immune (idiopathic) thrombocytopenia (ITP). Whether you are considering PROMACTA as a treatment option or are already taking it, you may receive information and support tailored to you that may include:

  • Living with chronic immune thrombocytopenia (ITP)
  • Finding a dosing schedule that works for you
  • Communicating with your health care team
  • Ways to help manage the emotional impact of chronic ITP


Enrollment is simple
Please complete the questions below to confirm your program enrollment.


Privacy notice
Novartis Pharmaceuticals Corporation and Novartis Group of Companies understand your personal and health information is private.


The personal information we collect from you, including your card or voucher usage, will be used to bring you information about products, programs, support, and services and to conduct market research. Please be assured that although we share your personal information with our business partners who work with us on these activities, we do not permit them to use your personal information for their own marketing purposes.


You may unsubscribe from our programs and services at any time by calling 1-888-669-6682. For more information about our privacy practices, please visit our website at

  1. 1/2:Enter your information
  2. 2/2:Review and submit
*Required field.

Responses to the following will help us to customize our communications to you.

My health is something that I myself am in charge of. *

The status of my physical health is determined largely by what I do (and don't do). *

How confident are you that you can ask your doctor about concerns that are related to your chronic ITP and PROMACTA? *

I have received previous treatment for my condition (select all that apply). *

Are you currently taking PROMACTA? *

Nplate (romiplostim) is a trademark of Amgen, Inc. Rituxan (rituximab) is a trademark of Biogen Inc. WinRho SDF is a trademark of Aptevo BioTherapeutics, LLC. 

Please complete all required fields.